Delivery Order SPE2D020D0005-SPE2D324F6796
- Not listed
- This federal contract award to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York, is for the delivery of 30-count packages of 8 mg ondansetron orally disintegrating tablets. Awarded by the Defense Logistics Agency (DLA) Troop Support Medical, this $3,946.20 firm fixed price delivery order does not have a set-aside designation. It is part of a larger $7 million-plus single-award indefinite delivery vehicle (IDV) contract held by Chartwell with DLA Troop Support...
- This is a $1,776.75 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract is for the supply of 4 mg ondansetron orally disintegrating tablets in 30-count packages. This delivery order is issued under Chartwell RX's existing Indefinite Delivery Contract (SPE2D020D0005) with DLA, which enables the company to manufacture and distribute a broad range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract, valued at $1,184.50, is a delivery order for the supply of 4,564,381,636 units of ondansetron ODT (orally disintegrating tablet) 4 mg, packaged in 30s. The contract is a firm fixed price agreement and has an ultimate completion date of April 29, 2024. Chartwell RX LLC is the prime contractor for this award,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York. The contract is for the supply of ondansetron orally disintegrating tablets, which are an antiemetic medication. The contract has a total ceiling value of $3,553.50 and runs through April 4, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a $4,143.51 delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York. The contract is for the delivery of 30-count packages of the anti-nausea medication ondansetron orally disintegrating tablets (ODT) 8 mg. This delivery order is issued under Chartwell RX's existing $7 million single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract, valued at $1,973.10, is for the delivery of 4,564,795,757 units of ondansetron ODT 8 mg tablets in 30-count packages. The contract has a firm fixed price pricing type and a completion date of June 7, 2024. Chartwell RX LLC is the prime contractor and has been awarded several other federal contracts, including...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York. The contract, valued at $3,553.50, is for the supply of Ondansetron ODT 4 mg tablets to the agency. This contract is part of a larger Indefinite Delivery Contract (SPE2D020D0005) with the DLA Troop Support Medical, valued at over $7 million, which enables Chartwell RX to manufacture and distribute a broad...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York. The $3,354.27 delivery order is for the supply of 4566683111 - Ondansetron ODT 8 mg Tablet in 30-count packages. The contract is a Firm Fixed Price Indefinite Delivery Vehicle (IDV) that allows Chartwell RX to manufacture and distribute a broad range of medications, including oral antibiotics, antivirals,...
- This federal contract award is for the delivery of ondansetron orally disintegrating tablets (4 mg, 30 count) to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York. The contract has a ceiling value of $2,842.80 and a completion date of July 7, 2025. It is a firm fixed-price delivery order contract, indicating that Chartwell RX LLC will be responsible for the full delivery of the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a for-profit pharmaceutical company located in Congers, New York. The contract is for the delivery of ondansetron orally disintegrating tablets (4 mg, 30-count) and has a ceiling value of $1,184.50. The contract is not set aside for any specific business type. Chartwell RX LLC is a prime contractor that has secured various pharmaceutical contracts with...
- SPE2D020D0005Indefinite Delivery Contract
- SPE2D020D0005-SPE2D324F6796Delivery Order
This contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York. The contract is for the delivery of 8 mg ondansetron oral disintegrating tablets in 30-count packages, with a firm fixed price of $2,959.65 and a completion date of March 12, 2024. Chartwell RX is an experienced federal contractor, holding multiple indefinite delivery vehicle (IDV) contracts with the Department of Veterans Affairs (VA) and DLA to supply a range of pharmaceutical products, including antibiotics, antivirals, and other medications, to support healthcare services for military personnel, veterans, and other government beneficiaries. This specific award is not designated as a set-aside contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 3/7/24 |